Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

7 terminated/withdrawn out of 599 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

11%

66 trials in Phase 3/4

Results Transparency

2%

2 of 87 completed trials have results

Key Signals

174 recruiting2 with results

Enrollment Performance

Analytics

Phase 2
142(38.7%)
N/A
127(34.6%)
Phase 3
44(12.0%)
Phase 1
27(7.4%)
Phase 4
22(6.0%)
Early Phase 1
5(1.4%)
367Total
Phase 2(142)
N/A(127)
Phase 3(44)
Phase 1(27)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (599)

Showing 20 of 599 trials
NCT07137832Phase 3Recruiting

OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular Treatment for Medium Vessel Occlusion

Role: lead

NCT07533526Not ApplicableNot Yet Recruiting

Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study

Role: lead

NCT07400523Phase 3Recruiting

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Role: lead

NCT06667609Active Not Recruiting

Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis

Role: lead

NCT07517510Phase 2Enrolling By Invitation

HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).

Role: collaborator

NCT06887881Not ApplicableRecruiting

PIMS vs PGT-A in Infertile PCOS Patients

Role: collaborator

NCT07488325Recruiting

Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images

Role: lead

NCT07504367Not ApplicableRecruiting

Large Language Models Assist in Tumor MDT

Role: lead

NCT06836869Not ApplicableRecruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Role: collaborator

NCT07494526Not Yet Recruiting

Chronic Kidney Disease and Metabolic Disorders in the Elderly

Role: collaborator

NCT07497204Completed

Splenic Artery Infusion Chemotherapy vs Systemic Chemotherapy in Advanced Pancreatic Body/Tail Cancer

Role: lead

NCT05982821Not ApplicableCompleted

Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules

Role: lead

NCT06146764Recruiting

CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Role: lead

NCT06681948Not ApplicableCompleted

The Ketogenic Diet in the Treatment of Alzheimer's Disease

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT07320963Phase 1Not Yet Recruiting

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Role: collaborator

NCT04881838Phase 3Active Not Recruiting

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Role: collaborator

NCT05681260Phase 3Recruiting

Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Role: collaborator

NCT06563245Phase 2Recruiting

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Role: collaborator